Kevin is an Asia-focused multilingual triple licensed pharmacist, entrepreneur and advisor managing businesses spanning multiple industries, with special interests in the healthcare and pharmaceutical industries. On top of running family business and his own company, he works as an Advisor for a leading Fortune Global 500 conglomerate and as a Partner for Asia Pacific's largest health and pharmaceutical information company.

Kevin also holds leadership positions in several international, regional and local non-governmental organisations, contributing back to society through empowerment:

• Director, International Pharmaceutical Federation (FIP) Foundation for Education   and Research (2021-2025)

• Global Lead for Development Goal 6 - Leadership Development, International Pharmaceutical Federation (FIP) Hub (2023-2025)

• Project Management Chairperson, Asian Young Pharmacist Group (2021-2022)

• Chairperson of Industry Chapter, Pharmaceutical Society of Singapore (2022-2024)

• Executive Committee Member, DKI Jakarta, Association of Indonesia Pharmacy Professionals / Persatuan Ahli Farmasi Indonesia (PAFI) (2022-2027)

He is the first pharmacist to be fully accredited by the Ministry of Health Singapore, the Ministry of Health Indonesia and Ministry of Health Malaysia. Additionally, Kevin is also the first Indonesian and Malaysian registered pharmacist to be awarded with Board Certified Medication Therapy Management Specialist (BCMTMS) title from the National Board of Medication Therapy Management (USA).

He is a recipient of a Master of Pharmacy scholarship from STARmeds (Systematic Tracking of At Risk Medicines), which is a collaborative research project among UK NIHR, Imperial College London, Erasmus University Rotterdam and Pancasila University.

Kevin was awarded the "Local Heroes" award by the Indonesian Pharmacist Association and the Indonesian Young Pharmacist Group.